Generation Bio(US:GBIO) ZACKSยท2024-11-06 23:45Group 1 - Generation Bio Co. reported a quarterly loss of $0.23 per share, better than the Zacks Consensus Estimate of a loss of $0.28, and improved from a loss of $0.43 per share a year ago, representing an earnings surprise of 17.86% [1] - The company posted revenues of $7.55 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 249.24%, compared to year-ago revenues of $2.15 million [2] - Generation Bio shares have increased approximately 32.7% since the beginning of the year, outperforming the S&P 500's gain of 21.2% [3] Group 2 - The current consensus EPS estimate for the coming quarter is -$0.24 on revenues of $2.16 million, and for the current fiscal year, it is -$1.80 on revenues of $12.48 million [7] - The Medical - Biomedical and Genetics industry, to which Generation Bio belongs, is currently ranked in the top 38% of over 250 Zacks industries, indicating a favorable outlook for the sector [8]